The biopharmaceutical industry is revealing increasing optimism regarding its growth prospects over the next 12 months. While the upward trend is a positive sign, it remains below the levels of confidence seen in 2022, finds data and analytics company GlobalData. In a recent survey, ‘The State of the Biopharmaceutical Industry 2024 (mid-year update)’, 73% of surveyed […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!